SOFWAVE MEDICAL LTD.

Communiqués SofWave Medical Ltd.

Actions

SOFW

IL0011754392

Temps Différé TEL AVIV STOCK EXCHANGE Autres places de cotation 10:52:22 09/06/2024			Varia. 5j.	Varia. 1 janv.
1 764 ^ILa	+1,97%		+8,29%	+28,57%

09/05	SofWave Medical Ltd. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
06/03	SofWave Medical Ltd. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Sofwave Medical Reports First Quarter 2024 Financial Results and Business Highlights	09/05	AQ
SofWave Medical : Presentation- Q1 2024 Summary-May 2024	09/05	PU
Sofwave Medical to Participate in the Needham 23rd Annual Healthcare Conference	28/03	AQ
Sofwave Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights	06/03	AQ
SofWave Medical : Presentation- Investor Meeting-March 2024	06/03	PU
Sofwave Medical to Present Pure Impact™ Strength and Muscle Toning Module’s First U.S. Industry Reveal at the 2024 American Academy of Dermatology (AAD) Annual Meeting	04/03	AQ
Sofwave Medical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference	28/02	AQ
Sofwave Medical Appoints Medical Aesthetics Industry Expert James Bartholomeusz to the Role of Chief Innovation Officer	12/02	AQ
Sofwave Medical Receives 510(k) Marketing Clearance for Pure Impact™ Strength and Muscle Toning Body Module Utilizing PlyoPulse™ EMS Technology	03/01	AQ
Sofwave Medical Receives FDA Clearance of SUPERB™ Technology For Improvement of the Appearance of Skin Laxity on the Upper Arm	26/12	AQ
Sofwave Earns Frost & Sullivan's 2023 North American Technology Innovation Leadership Award for Developing a Sophisticated Skin Tightening Ultrasound Technology with Minimal Downtime	20/11	AQ
Sofwave Medical Reports Third Quarter 2023 Financial Results and Business Highlights	08/11	AQ
Sofwave Medical Announces FDA Clearance of SUPERB™ Technology For Treatment of Acne Scars	30/08/23	AQ
Sofwave Medical Reports Second Quarter and First Half 2023 Financial Results and Recent Business Highlights	08/08/23	AQ
SofWave Medical : Presentation -August 2023	08/08/23	PU
Sofwave™ Gains Additional U.S. Patent Protection For the Company’s Proprietary SUPERB™ Technology	05/07/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Comme les experts, accédez à tous les transcripts et dénichez avant tout le monde les meilleures opportunités.

Débloquez-les Maintenant !

fermer